Study of Urinary Gonadotrophin Peptide and Its Relationship with Beta-Core Fragment
Author Information
Author(s): A. Kardanal, K.D. Bagshawel, B. Coles, D. Read, M. Taylor
Primary Institution: Cancer Research Campaign Laboratories, Department of Medical Oncology, Charing Cross Hospital
Hypothesis
The study investigates the characteristics of urinary gonadotrophin peptide (UGP) and its association with the beta-core fragment of human chorionic gonadotrophin (hCG).
Conclusion
The study found that UGP is associated with the beta-core fragment and other peptides, suggesting a complex relationship that may be relevant for cancer detection.
Supporting Evidence
- UGP was detected in 93% of tumors examined immunohistochemically.
- UGP cross-reacts with antisera to hCG beta-core fragment.
- Bioassay studies indicated that biological activity could be attributed to contamination with hCG.
Takeaway
Scientists looked at a special substance in urine that might help find cancer, and they found it is linked to another important substance from pregnancy.
Methodology
The study used high pressure liquid chromatography, amino acid sequencing, and immunoassays to analyze UGP and its components.
Limitations
The study's findings may be influenced by potential contamination with hCG, and the association of peptides may not be conclusively established.
Participant Demographics
The study included urine samples from patients with various types of cancer and normal subjects.
Want to read the original?
Access the complete publication on the publisher's website